Cargando…

Are Drug Eluting Stents Worth Triple Therapy?

Detalles Bibliográficos
Autor principal: Heidenreich, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586481/
https://www.ncbi.nlm.nih.gov/pubmed/28862966
http://dx.doi.org/10.1161/JAHA.117.006983
_version_ 1783261825845952512
author Heidenreich, Paul
author_facet Heidenreich, Paul
author_sort Heidenreich, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-5586481
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55864812017-09-11 Are Drug Eluting Stents Worth Triple Therapy? Heidenreich, Paul J Am Heart Assoc Editorial John Wiley and Sons Inc. 2017-08-21 /pmc/articles/PMC5586481/ /pubmed/28862966 http://dx.doi.org/10.1161/JAHA.117.006983 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Editorial
Heidenreich, Paul
Are Drug Eluting Stents Worth Triple Therapy?
title Are Drug Eluting Stents Worth Triple Therapy?
title_full Are Drug Eluting Stents Worth Triple Therapy?
title_fullStr Are Drug Eluting Stents Worth Triple Therapy?
title_full_unstemmed Are Drug Eluting Stents Worth Triple Therapy?
title_short Are Drug Eluting Stents Worth Triple Therapy?
title_sort are drug eluting stents worth triple therapy?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586481/
https://www.ncbi.nlm.nih.gov/pubmed/28862966
http://dx.doi.org/10.1161/JAHA.117.006983
work_keys_str_mv AT heidenreichpaul aredrugelutingstentsworthtripletherapy